We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
451
TAL Education Group
TAL
$6.85B
$10.6M 0.04%
309,860
-19,759
-6% -$688K
NDAQ icon
452
Nasdaq
NDAQ
$53.2B
$10.6M 0.04%
318,897
+10,800
+4% +$359K
ING icon
453
ING
ING
$99.8B
$10.5M 0.04%
1,008,793
-213,972
-17% -$2.25M
CDW icon
454
CDW
CDW
$18.6B
$10.5M 0.04%
84,920
+3,605
+4% +$413K
APTV icon
455
Aptiv
APTV
$12.3B
$10.4M 0.04%
118,912
+6,120
+5% +$511K
HES
456
DELISTED
Hess
HES
$10.4M 0.04%
171,697
+21,056
+14% +$1.31M
SBS icon
457
Sabesp
SBS
$19.2B
$10.4M 0.04%
4,500,505
+639,909
+17% +$1.61M
BKR icon
458
Baker Hughes
BKR
$59.5B
$10.4M 0.04%
446,524
+45,223
+11% +$1.06M
EXPE icon
459
Expedia Group
EXPE
$35.2B
$10.3M 0.04%
76,978
+10,860
+16% +$1.43M
GAP
460
The Gap Inc
GAP
$7.34B
$10.3M 0.04%
596,019
+36,191
+6% +$643K
MSCI icon
461
MSCI
MSCI
$41.9B
$10.3M 0.04%
47,492
+5,003
+12% +$1.16M
VOYA icon
462
Voya Financial
VOYA
$9.09B
$10.3M 0.04%
189,212
+23,044
+14% +$1.23M
CMS icon
463
CMS Energy
CMS
$22.7B
$10.3M 0.04%
161,020
+3,631
+2% +$220K
BIDU icon
464
Baidu
BIDU
$36.5B
$10.3M 0.04%
100,046
+53,712
+116% +$5.77M
BCS icon
465
Barclays
BCS
$93.4B
$10.3M 0.04%
1,400,087
-68,132
-5% -$493K
NTES icon
466
NetEase
NTES
$84.4B
$10.3M 0.04%
192,530
+3,670
+2% +$187K
AFG icon
467
American Financial Group
AFG
$11.8B
$10.2M 0.04%
94,636
+15,411
+19% +$1.6M
DOV icon
468
Dover
DOV
$27.5B
$10.2M 0.04%
102,382
-3,167
-3% -$304K
CTVA icon
469
Corteva
CTVA
$59.8B
$10.1M 0.04%
360,429
+22,442
+7% +$649K
NRG icon
470
NRG Energy
NRG
$28.3B
$10.1M 0.04%
254,741
+2,055
+0.8% +$74.3K
AMX icon
471
America Movil
AMX
$76B
$10.1M 0.04%
678,195
+118,007
+21% +$1.69M
MAN icon
472
ManpowerGroup
MAN
$2.41B
$10M 0.04%
118,965
-8,269
-6% -$721K
CHE icon
473
Chemed
CHE
$7.1B
$10M 0.04%
23,965
+6,072
+34% +$2.48M
SAM icon
474
Boston Beer
SAM
$1.93B
$9.99M 0.04%
27,437
+7,048
+35% +$2.77M
BHF icon
475
Brighthouse Financial
BHF
$3.64B
$9.99M 0.04%
246,787
+154,498
+167% +$5.75M

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.